K Arakawa

789 total citations
32 papers, 622 citations indexed

About

K Arakawa is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K Arakawa has authored 32 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K Arakawa's work include Genetic factors in colorectal cancer (4 papers), Heart Failure Treatment and Management (4 papers) and Renin-Angiotensin System Studies (4 papers). K Arakawa is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Heart Failure Treatment and Management (4 papers) and Renin-Angiotensin System Studies (4 papers). K Arakawa collaborates with scholars based in Japan, United States and Italy. K Arakawa's co-authors include Manabu Sasaguri, Munehito Ideishi, Kohei Noda, Masaharu Ikeda, A. M. Jézéquel, Jan W. Steiner, Motoko Naitoh, M Murakami, Hidetomo Nakamoto and Hiromichi Suzuki and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cardiovascular Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

K Arakawa

28 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Arakawa Japan 10 242 170 147 91 73 32 622
A. Algra Netherlands 11 261 1.1× 144 0.8× 297 2.0× 135 1.5× 53 0.7× 24 1.3k
G. Sponer United States 18 490 2.0× 216 1.3× 78 0.5× 214 2.4× 28 0.4× 63 1.0k
M.P. Gordge United Kingdom 15 141 0.6× 142 0.8× 185 1.3× 73 0.8× 52 0.7× 28 746
Leslie A. Garrett United States 17 223 0.9× 169 1.0× 91 0.6× 180 2.0× 48 0.7× 38 1.1k
Judith B. Van Liew United States 14 181 0.7× 214 1.3× 115 0.8× 52 0.6× 56 0.8× 44 864
Samy Hadjadj France 16 177 0.7× 196 1.2× 122 0.8× 96 1.1× 18 0.2× 32 808
Yukiko Hasuike Japan 22 54 0.2× 195 1.1× 94 0.6× 102 1.1× 107 1.5× 61 1.3k
Shigeru Kiyama Japan 8 123 0.5× 146 0.9× 71 0.5× 66 0.7× 40 0.5× 22 461
N. Dowd Ireland 11 253 1.0× 53 0.3× 56 0.4× 226 2.5× 30 0.4× 22 747
Jan Beneš Czechia 12 319 1.3× 192 1.1× 72 0.5× 55 0.6× 33 0.5× 40 814

Countries citing papers authored by K Arakawa

Since Specialization
Citations

This map shows the geographic impact of K Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Arakawa more than expected).

Fields of papers citing papers by K Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Arakawa. The network helps show where K Arakawa may publish in the future.

Co-authorship network of co-authors of K Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of K Arakawa. A scholar is included among the top collaborators of K Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Arakawa. K Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arakawa, K, Keisuke Hata, Hiroaki Nozawa, et al.. (2019). Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients. Anticancer Research. 39(3). 1425–1432. 3 indexed citations
2.
3.
Arakawa, K, Keisuke Hata, Kazushige Kawai, et al.. (2018). Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines. Anticancer Research. 38(8). 4871–4876. 8 indexed citations
4.
Arakawa, K, Kazushige Kawai, Soichiro Ishihara, et al.. (2017). Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study. Diseases of the Colon & Rectum. 60(10). 1041–1049. 18 indexed citations
5.
Arakawa, K, Soichiro Ishihara, Kazushige Kawai, et al.. (2016). Asynchronous bilateral anastomosis site sigmoid colon cancer after ureterosigmoidostomy: a case report. World Journal of Surgical Oncology. 14(1). 180–180. 1 indexed citations
6.
Arakawa, K, Tomomichi Kiyomatsu, Soichiro Ishihara, et al.. (2016). A case report of anorectal malignant melanoma with mucosal skipped lesion. International Journal of Surgery Case Reports. 24(C). 206–210. 4 indexed citations
7.
Gan, Jinping, Paul L. Skipper, Manuela Gago-Domínguez, et al.. (2004). Alkylaniline-Hemoglobin Adducts and Risk of Non-Smoking-Related Bladder Cancer. JNCI Journal of the National Cancer Institute. 96(19). 1425–1431. 55 indexed citations
8.
Fukami, Hironobu, Seiichi Imajo, Saki Kakutani, et al.. (2000). Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.. PubMed. 17(1). 69–84. 28 indexed citations
9.
Sasaguri, Manabu, Noriko Matsumoto, Kazuki Noda, et al.. (1997). Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension. European Journal of Clinical Pharmacology. 53(3-4). 197–201. 18 indexed citations
10.
Naitoh, Motoko, Hiromichi Suzuki, K Arakawa, et al.. (1997). Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 272(2). H679–H687. 23 indexed citations
11.
Arakawa, K, et al.. (1996). The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.. PubMed. 28(2). 631–2. 5 indexed citations
12.
Naitoh, Motoko, Hiromichi Suzuki, M Murakami, et al.. (1994). Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. American Journal of Physiology-Heart and Circulatory Physiology. 267(6). H2245–H2254. 118 indexed citations
13.
Ideishi, Munehito, Shinji Miura, Takanori Sakai, et al.. (1994). Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats.. PubMed. 5. 99–104. 9 indexed citations
15.
Noda, Kohei, Manabu Sasaguri, Munehito Ideishi, Masaharu Ikeda, & K Arakawa. (1993). Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovascular Research. 27(2). 334–340. 113 indexed citations
16.
Noda, Kohei, Manabu Sasaguri, Munehito Ideishi, Masaharu Ikeda, & K Arakawa. (1992). Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.. PubMed. 38 ( Pt 3). 217–27. 3 indexed citations
17.
Arakawa, K. (1990). Anal fistulas in female patients.. Nihon Daicho Komonbyo Gakkai Zasshi. 43(6). 1063–1069. 1 indexed citations
18.
Ideishi, Munehito, Manabu Sasaguri, Masatoshi Ikeda, & K Arakawa. (1989). Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.. PubMed. 11(4). 441–51. 1 indexed citations
19.
Arakawa, K & Makoto Nakamura. (1967). Studies on human angiotensin.. PubMed. 21(1). Suppl 2:101+–Suppl 2:101+. 4 indexed citations
20.
Arakawa, K, et al.. (1964). [ON THE APPLICATION OF ENZYMATIC MUCINOLYSIS IN X-RAY DIAGNOSIS OF THE STOMACH].. PubMed. 24. 1011–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026